>>  Home  >>  Scientific Publications  >>  2018



Scientific Publications

Medical Library

Business Opportunities


Education & Training

Biological Safety

Unified Culture Collection

Special Pathogens Lab

Reference Materials

Related Links


Contact Us



— 2021—

Amemiya K, Dankmeyer JL, Bernhards RC, et al. Activation of toll-like receptors by live gram-negative bacterial pathogens reveals mitigation of TLR4 responses and activation of TLR5 by flagella. Front Cell Infect Microbiol. 2021;11:745325. https://doi.org/10.3389/fcimb.2021.745325

Arnold CE, Shoemaker CJ, Smith DR, et al. Host response transcriptomic analysis of Crimean-Congo hemorrhagic fever pathogenesis in the cynomolgus macaque model. Sci Rep. 2021;11(1):19807. https://doi.org/10.1038/s41598-021-99130-1

Bachert BA, Richardson JB, Mlynek KD, et al. Development, phenotypic characterization and genomic analysis of a Francisella tularensis panel for tularemia vaccine testing. Front Microbiol. 2021;12:725776. https://doi.org/10.3389/fmicb.2021.725776

Beitzel BF, Radoshitzky SR, Di Paola N, et al. On‐demand patient‐specific phenotype‐to‐genotype Ebola virus characterization. Viruses. 2021;13(10):2010. https://doi.org/10.3390/v13102010

Biryukov S, Dankmeyer JL, Shamsuddin Z, et al. Impact of toll-like receptor-specific agonists on the host immune response to the Yersinia pestis plague rF1V vaccine. Front Immunol. 2021;12:726416. https://doi.org/10.3389/fimmu.2021.726416

Blair PW, Kortepeter MG, Downey LG, et al. Intensive care unit-like care of nonhuman primates with Ebola virus disease. J Infect Dis. 2021;224(4):632-642. https://doi.org/10.1093/infdis/jiaa781

Boonyalai N, Thamnurak C, Sai-Ngam P, et al. Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand. Sci Rep. 2021;11(1):13419. https://doi.org/10.1038/s41598-021-92735-6    

Bowling PA, Bencivenga MA, Leyva ME, et al. Effects of a heated anesthesia breathing circuit on body temperature in anesthetized rhesus macaques (macaca mulatta). J Am Assoc Lab Anim Sci. 2021;60(6):675-680. https://doi.org/10.30802/aalas-jaalas-21-000058

Brocato RL, Altamura LA, Carey BD, et al. Comparison of transcriptional responses between pathogenic and nonpathogenic hantavirus infections in Syrian hamsters using NanoString. PLoS Negl Trop Dis. 2021;15(8):e0009592. https://doi.org/10.1371/journal.pntd.0009592

Brocato RL, Kwilas SA, Josleyn MD, et al. Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines. Vaccine. 2021;39(7):1101-1110. https://doi.org/10.1016/j.vaccine.2021.01.002

Brocato RL, Kwilas SA, Kim RK, et al. Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters. NPJ Vaccines. 2021;6(1):16. https://doi.org/10.1038/s41541-020-00279-z

Cai Y, Yu S, Chi X, Radoshitzky SR, Kuhn JH, Berger EA. An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells. PLoS One. 2021;16(1):e0245024. https://doi.org/10.1371/journal.pone.0245024

Cai Y, Yu S, Fang Y, et al. Development and characterization of a cdna-launch recombinant simian hemorrhagic fever virus expressing enhanced green fluorescent protein: ORF 2b' is not required for in vitro virus replication. Viruses. 2021;13(4):632. https://doi.org/10.3390/v13040632

Chapman NS, Zhao H, Kose N, et al. Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition. Proc Natl Acad Sci U S A. 2021;118(14):e2025642118. https://doi.org/10.1073/pnas.2025642118

Chen Y, Toth EA, Ruan B, et al. Engineering subtilisin proteases that specifically degrade active RAS. Commun Biol. 2021;4(1):299. https://doi.org/10.1038/s42003-021-01818-7

Chiang CY, Zhong Y, Ward MD, et al. Proteomic analysis of non-human primate peripheral blood mononuclear cells during Burkholderia mallei infection reveals a role of ezrin in glanders pathogenesis. Front Microbiol. 2021;12:625211. https://doi.org/10.3389/fmicb.2021.625211

Clayton NP, Jain A, Halasohoris SA, et al. In vitro and in vivo characterization of tebipenem (TBP), an orally active carbapenem, against biothreat pathogens. Antimicrob Agents Chemother. 2021;65(5):e02385-20. https://doi.org/10.1128/aac.02385-20

Cote CK, Biryukov SS, Klimko CP, et al. Protection elicited by attenuated live Yersinia pestis vaccine strains against lethal infection with virulent Y. pestis. Vaccines (Basel). 2021;9(2):161. https://doi.org/10.3390/vaccines9020161

Cote CK, Weidner JM, Klimko C, et al. Biological validation of a chemical effluent decontamination system. Appl Biosaf. 2021;26(1):23-32. https://doi.org/10.1089/apb.21.937967

Crooks CM, Weiler AM, Rybarczyk SL, et al. African-lineage Zika virus replication dynamics and maternal-fetal interface infection in pregnant rhesus macaques. J Virol. 2021;95(16):e0222020. https://doi.org/10.1128/jvi.02220-20

Davis S, Milechin L, Patel T, et al. Detecting pathogen exposure during the non-symptomatic incubation period using physiological data: proof of concept in non-human primates. Front Physiol. 2021;12:691074. https://doi.org/10.3389/fphys.2021.691074

De Luca E, Álvarez-Narváez S, Maboni G, et al. Comparative genomics analyses support the reclassification of bisgaard taxon 40 as Mergibacter gen. nov., with Mergibacter septicus sp. nov. as type species: novel insights into the phylogeny and virulence factors of a Pasteurellaceae family member associated with mortality events in seabirds. Front Microbiol. 2021;12:667356. https://doi.org/10.3389/fmicb.2021.667356

Dixon BC, Culbreth MJ, Kumsher DM, Carbaugh CM, Fetterer DP, Reiter CP. Mid-tibiofibular amputation as a method of terminal blood collection in xenopus laevis. J Am Assoc Lab Anim Sci. 2021;60(5):582-586. https://doi.org/10.30802/aalas-jaalas-21-000005

Downs I, Johnson JC, Rossi F, et al. Natural history of aerosol-induced Ebola virus disease in rhesus macaques. Viruses. 2021;13(11):2297. https://doi.org/10.3390/v13112297

Engdahl TB, Kuzmina NA, Ronk AJ, et al. Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection. Cell Rep. 2021;35(5):109086. https://doi.org/10.1016/j.celrep.2021.109086

Evans TS, Myat TW, Hom NS, et al. Seroepidemiologic survey of Crimean-Congo hemorrhagic fever virus in logging communities, Myanmar. Emerg Infect Dis. 2021;27(6):1709-1713. https://doi.org/10.3201/eid2706.203223

Fall G, Diallo D, Soumaila H, et al. First detection of the West Nile virus Koutango lineage in sandflies in Niger. Pathogens. 2021;10(3):257. https://doi.org/10.3390/pathogens10030257

Fels JM, Maurer DP, Herbert AS, et al. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever. Cell. 2021;184(13):3486-3501.e3421. https://doi.org/10.1016/j.cell.2021.05.001

Franz DR, Le Duc JW. Technology advances, high-risk research, and a safe way forward. mBio. 2021;12(5):e0237321. https://doi.org/10.1128/mbio.02373-21

Frick OM, Livingston VA, Whitehouse CA, et al. The natural history of aerosolized Francisella tularensis infection in cynomolgus macaques. Pathogens. 2021;10(5):597. https://doi.org/10.3390/pathogens10050597

Garcia-Rodriguez C, Yan S, Geren IN, et al. A four-monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotypes C and D. Toxins (Basel). 2021;13(9):641. https://doi.org/10.3390/toxins13090641

Golden JW, Zeng X, Cline CR, et al. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease. J Gen Virol. 2021;102(5):001599. https://doi.org/10.1099/jgv.0.001599

Grund ME, Kramarska E, Choi SJ, et al. Predictive and experimental immunogenicity of burkholderia collagen‐like protein 8‐derived antigens. Vaccines. 2021;9(11). https://doi.org/10.3390/cells10030495

Grund ME, Soo JC, Cote CK, Berisio R, Lukomski S. Thinking outside the bug: targeting outer membrane proteins for Burkholderia vaccines. Cells. 2021;10(3). https://doi.org/10.3390/cells10030495

Guito JC, Prescott JB, Arnold CE, et al. Asymptomatic infection of Marburg virus reservoir bats is explained by a strategy of immunoprotective disease tolerance. Curr Biol. 2021;31(2):257-270.e255. https://doi.org/10.1016/j.cub.2020.10.015

Gupta Y, Kumar S, Zak SE, et al. Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach. Bioorg Med Chem. 2021;47:116393. https://doi.org/10.1016/j.bmc.2021.116393

Gupta Y, Maciorowski D, Zak SE, et al. Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays. Methods. 2021;195:57-71. https://doi.org/10.1016/j.ymeth.2021.01.003

Gupta Y, Maciorowski D, Zak SE, et al. Heparin: a simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy. Int J Biol Macromol. 2021;183:203-212. https://doi.org/10.1016/j.ijbiomac.2021.04.148

Haddow AD, Clarke SC. Inaccuracies in Google's health-based knowledge panels perpetuate widespread misconceptions involving infectious disease transmission. Am J Trop Med Hyg. 2021;104(6):2293-2297. https://doi.org/10.4269/ajtmh.21-0216

Haddow AD, Rowland TE, Norris SL, et al. No evidence of rVSV-Ebola virus vaccine replication or dissemination in the sand fly Phlebotomus papatasi. Am J Trop Med Hyg. 2021;104(3):1093-1095. https://doi.org/10.4269/ajtmh.20-0951

Haddow, AD, Watt, TR, Bloomfield, HA, Fetterer, DP, & Harbourt, DE. Modeling the stability of SARS-CoV-2 on personal protective equipment (PPE). Am J Trop Med Hyg. 2021;104(2):549-551. https://doi.org/10.4269/ajtmh.20-1508

Halasohoris SA, Scarff JM, Pysz LM, et al. In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens. J Antibiot (Tokyo). 2021;74(12):884-892. https://doi.org/10.1038/s41429-021-00472-9

Haslwanter D, Dieterle ME, Wec AZ, et al. A combination of receptor-binding domain and n-terminal domain neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants. mBio. 2021;12(5):e0247321. https://doi.org/10.1128/mbio.02473-21

Herring S, Oda JM, Wagoner J, et al. Erratum for Herring et al., "Inhibition of Arenaviruses by combinations of orally available approved drugs". Antimicrob Agents Chemother. 2021;65(6):e00653-21. https://doi.org/10.1128/aac.00653-21

Herring S, Oda JM, Wagoner J, et al. Inhibition of Arenaviruses by combinations of orally available approved drugs. Antimicrob Agents Chemother. 2021;65(4):e01146-20. https://doi.org/10.1128/aac.01146-20

Hierweger MM, Koch MC, Rupp M, et al. Novel filoviruses, hantavirus, and rhabdovirus in freshwater fish, Switzerland, 2017. Emerg Infect Dis. 2021;27(12):3082-3091. https://doi.org/10.3201/eid2712.210491

Hollidge BS, Cohen CA, Akuoku Frimpong J, Badger CV, Dye JM, Schmaljohn CS. Toll-like receptor 4 mediates blood-brain barrier permeability and disease in C3H mice during Venezuelan equine encephalitis virus infection. Virulence. 2021;12(1):430-443. https://doi.org/10.1080/21505594.2020.1870834

Hulseberg CE, Kumar R, Di Paola N, et al. Molecular analysis of the 2012 Bundibugyo virus disease outbreak. Cell Rep Med. 2021;2(8):100351. https://doi.org/10.1016/j.xcrm.2021.100351

Jelacic TM, Ribot WJ, Tobery SA, Chabot DJ, Friedlander AM. Poly-γ-Glutamic acid encapsulation of Bacillus anthracis inhibits human dendritic cell responses. Immunohorizons. 2021;5(2):81-89. https://doi.org/10.4049/immunohorizons.2100004

Jiang J, Ramos SJ, Bangalore P, et al. Multivalent DNA vaccines as a strategy to combat multiple concurrent epidemics: mosquito-borne and hemorrhagic fever viruses. Viruses. 2021;13(3):382. https://doi.org/10.3390/v13030382

Johnston SC, Ricks KM, Jay A, et al. Development of a coronavirus disease 2019 nonhuman primate model using airborne exposure. PLoS One. 2021;16(2):e0246366. https://doi.org/10.1371/journal.pone.0246366

Johnston SC, Wilhelmsen CL, Shamblin J, et al. Delayed disease in cynomolgus macaques exposed to Ebola virus by an intranasal route. Front Immunol. 2021;12:709772. https://doi.org/10.3389/fimmu.2021.709772

Keasey SL, Zhao BM, Ulrich RG, Suh MJ. Proteomic analysis of antibiotic susceptibility in Enterobacteriaceae. Methods Mol Biol. 2021;2296:381-392. https://doi.org/10.1007/978-1-0716-1358-0_22

Kijek TM, Bozue JA, Panchal RG, Litosh VA, Woodard RW, Ahmed SA. A direct spectropolarimetric assay of arabinose 5-phosphate isomerase. Anal Biochem. 2021;622:114116. https://doi.org/10.1016/j.ab.2021.114116

King HAD, Gordon Joyce M, Lakhal-Naouar I, et al. Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. Proc Natl Acad Sci U S A. 2021;118(38):e2106433118. https://doi.org/10.1073/pnas.2106433118

Kinganda-Lusamaki E, Black A, Mukadi DB, et al. Integration of genomic sequencing into the response to the Ebola virus outbreak in Nord Kivu, Democratic Republic of the Congo. Nat Med. 2021;27(4):710-716. https://doi.org/10.1038/s41591-021-01302-z

Kuehnert PA, Stefan CP, Badger CV, Ricks KM. Crimean-Congo hemorrhagic fever virus (CCHFV): a silent but widespread threat. Curr Trop Med Rep. 2021:1-7. https://doi.org/10.1007/s40475-021-00235-4

Kuhn JH, Adkins S, Agwanda BR, et al. 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales. Arch Virol. 2021;166(12):3513-3566. https://doi.org/10.1007/s00705-021-05143-6

Kuhn JH, Adkins S, Agwanda BR, et al. Correction to: 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales. Arch Virol. 2021;166(12):3567-3579. https://doi.org/10.1007/s00705-021-05266-w

Kumar S, Gupta Y, Zak SE, et al. A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): in silico and in vitro investigations. RSC Med Chem. 2021;12(10):1757-1764. https://doi.org/10.1039/d1md00202c

Larson PA, Bartlett ML, Garcia K, et al. Genomic features of humoral immunity support tolerance model in Egyptian rousette bats. Cell Rep. 2021;35(7):109140. https://doi.org/10.1016/j.celrep.2021.109140

Legler PM, Little SF, Senft J, et al. Treatment of experimental anthrax with pegylated circularly permuted capsule depolymerase. Sci Transl Med. 2021;13(623):eabh1682. https://doi.org/10.1126/scitranslmed.abh1682

Li T, Chung HK, Pireku PK, et al. Rapid high-throughput whole-genome sequencing of SARS-CoV-2 by using one-step reverse transcription-pcr amplification with an integrated microfluidic system and next-generation sequencing. J Clin Microbiol. 2021;59(5):e02784-20. https://doi.org/10.1128/jcm.02784-20

Lin JT, Waltmann A, Moser KA, et al. Selection of cytochrome b mutants is rare among plasmodium falciparum patients failing treatment with atovaquone-proguanil in Cambodia. Antimicrob Agents Chemother. 2021;65(3):e01249-20. https://doi.org/10.1128/aac.01249-20

Liu JL, Webb EM, Zabetakis D, et al. Stabilization of a broadly neutralizing anti-Chikungunya virus single domain antibody. Front Med (Lausanne). 2021;8:626028. https://doi.org/10.3389/fmed.2021.626028

Luban J, Sattler RA, Mühlberger E, et al. The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines. Virus Res. 2021;292:198246. https://doi.org/10.1016/j.virusres.2020.198246

Maccio U, Zinkernagel AS, Shambat SM, et al. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine. 2021;63:103182. https://doi.org/10.1016/j.ebiom.2020.103182

Martchenko Shilman M, Bartolo G, Alameh S, et al. In vivo activity of repurposed amodiaquine as a host-targeting therapy for the treatment of anthrax. ACS Infect Dis. 2021;7(8):2176-2191. https://doi.org/10.1021/acsinfecdis.1c00190

McCurdy S, Duffy E, Hickman M, Halasohoris S, Zumbrun SD. Efficacy of delafloxacin against the biothreat pathogen Burkholderia pseudomallei. Antimicrob Agents Chemother. 2021;65(10):e0073621. https://doi.org/10.1128/aac.00736-21

Montgomery VA, Lindsey CY, Smith LA, Webb RP. Development of an o-pthalaldehyde (OPA) assay to measure protein content in Ricin Vaccine E. coli (RVEc™). Vaccine. 2021;39(3):564-570. https://doi.org/10.1016/j.vaccine.2020.12.008

Mou S, Jenkins CC, Okaro U, Dhummakupt ES, Mach PM, DeShazer D. The Burkholderia pseudomallei hmqA-G locus mediates competitive fitness against environmental gram-positive bacteria. Microbiol Spectr. 2021;9(1):e0010221. https://doi.org/10.1128/spectrum.00102-21

Newman CM, Tarantal AF, Martinez ML, et al. Early embryonic loss following intravaginal Zika virus challenge in rhesus macaques. Front Immunol. 2021;12:686437. https://doi.org/10.3389/fimmu.2021.686437

Niemuth NA, Fallacara D, Triplett CA, et al. Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease. PLoS One. 2021;16(7):e0252874. https://doi.org/10.1371/journal.pone.0252874

Ohrman C, Sahl JW, Sjodin A, et al. Reorganized genomic taxonomy of Francisellaceae enables design of robust environmental PCR assays for detection of Francisella tularensis. Microorganisms. 2021; 9(1):146. https://doi.org/10.3390/microorganisms9010146

Okaro U, George S, Anderson B. What Is in a Cat Scratch? Growth of Bartonella henselae in a Biofilm. Microorganisms. 2021;9(4):835. https://doi.org/10.3390/microorganisms9040835

Osorio-Guarín JA, Gopaulchan D, Quanckenbush C, Lennon AM, Umaharan P, Cornejo OE. Comparative transcriptomic analysis reveals key components controlling spathe color in Anthurium andraeanum (Hort.). PLoS ONE. 2021;16(12):e0261364. https://doi.org/10.1371/journal.pone.0261364

Papp-Wallace KM, Shapiro AB, Becka SA, et al. In vitro antibacterial activity and in vivo efficacy of sulbactam-durlobactam against pathogenic Burkholderia species. Antimicrob Agents Chemother. 2021;65(3):e01930-20. https://doi.org/10.1128/aac.01930-20

Paquin-Proulx D, Gunn BM, Alrubayyi A, et al. Associations between antibody Fc-mediated effector functions and long-term sequelae in Ebola virus survivors. Front Immunol. 2021;12:682120. https://doi.org/10.3389/fimmu.2021.682120

Pérez-Sautu U, Wiley MR, Prieto K, et al. Novel viruses in hard ticks collected in the Republic of Korea unveiled by metagenomic high-throughput sequencing analysis. Ticks Tick Borne Dis. 2021;12(6):101820. https://doi.org/10.1016/j.ttbdis.2021.101820

Phelps AL, O’brien LM, Ulaeto DO, et al. Cross-strain neutralizing and protective monoclonal antibodies against EEEV or WEEV. Viruses. 2021;13(11):2231. https://doi.org/10.3390/v13112231

Pierson BC, Cardile AP, Okwesili AC, et al. Safety and immunogenicity of an inactivated eastern equine encephalitis virus vaccine. Vaccine. 2021;39(20):2780-2790. https://doi.org/10.1016/j.vaccine.2021.03.030

Pinky L, Burke CW, Russell CJ, Smith AM. Quantifying dose-, strain-, and tissue-specific kinetics of parainfluenza virus infection. PLoS Comput Biol. 2021;17(8):e1009299. https://doi.org/10.1371/journal.pcbi.1009299

Rappazzo CG, Tse LV, Kaku CI, et al. Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science. 2021;371(6531):823-829. https://doi.org/10.1126/science.abf4830

Robie ER, Zemke JN, Toh TH, et al. Chikungunya and Zika viruses not detected among patients with dengue-like illness, Sarawak, Malaysia. Asia Pac J Public Health. 2021;33(8):995-996. https://doi.org/10.1177/10105395211007631

Rosario-Acevedo R, Biryukov SS, Bozue JA, Cote CK. Plague prevention and therapy: Perspectives on current and future strategies. Biomedicines. 2021;9(10):1421. https://doi.org/10.3390/biomedicines9101421

Saikh KU. MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity. Immunol Res. 2021;69(2):117-128. https://doi.org/10.1007/s12026-021-09188-2

Saikh KU, Ranji CM. Cells stimulated with more than one toll-like receptor-ligand in the presence of a myd88 inhibitor augmented interferon-β via MyD88-independent signaling pathway. Viral Immunol. 2021;34(9):646-652. https://doi.org/10.1089/vim.2021.0020

Sen E, Kota KP, Panchal RG, Bavari S, Kiris E. Screening of a focused ubiquitin-proteasome pathway inhibitor library identifies small molecules as novel modulators of Botulinum Neurotoxin Type A toxicity. Front Pharmacology. 2021;12:763950. https://doi.org/10.3389/fphar.2021.763950

Shoudy LE, Namjoshi P, Giordano G, et al. The O-Ag antibody response to Francisella is distinct in rodents and higher animals and can serve as a correlate of protection. Pathogens. 2021;10(12):1646. https://doi.org/10.3390/pathogens10121646

Shrestha B, Shah Z, Morgan AP, et al. Distribution and temporal dynamics of Plasmodium falciparum chloroquine resistance transporter mutations associated with piperaquine resistance in Northern Cambodia. J Infect Dis. 2021;224(6):1077-1085. https://doi.org/10.1093/infdis/jiab055

Shu Q, Kenny T, Fan J, Lyon CJ, Cazares LH, Hu TY. Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants. PLoS Pathogens. 2021;17(11):e1010039. https://doi.org/10.1371/journal.ppat.1010039

Stefan CP, Arnold CE, Shoemaker CJ, et al. Transcriptomic analysis reveals host mirnas correlated with immune gene dysregulation during fatal disease progression in the Ebola virus cynomolgus macaque disease model. Microorganisms. 2021;9(3):665. https://doi.org/10.3390/microorganisms9030665

Strange DP, Jiyarom B, Sadri-Ardekani H, et al. Paracrine IFN response limits ZIKV infection in human sertoli cells. Front Microbiol. 2021;12:667146. https://doi.org/10.3389/fmicb.2021.667146

Suschak JJ, Golden JW, Fitzpatrick CJ, et al. A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice. NPJ Vaccines. 2021;6(1):31. https://doi.org/10.1038/s41541-021-00293-9

Trefry JC, Rossi FD, Accardi MV, et al. The utilization of advance telemetry to investigate critical physiological parameters including electroencephalography in cynomolgus macaques following aerosol challenge with eastern equine encephalitis virus. PLoS Negl Trop Dis. 2021;15(6):e0009424. https://doi.org/10.1371/journal.pntd.0009424

Trevino SR, Dankmeyer JL, Fetterer DP, et al. Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model. PLoS Negl Trop Dis. 2021;15(2):e0009125. https://doi.org/10.1371/journal.pntd.0009125

Turell MJ, Dohm DJ, Fernandez R, Klein TA. Vector competence of peruvian mosquitoes for two Orthobunyaviruses isolated from mosquitoes captured in Peru. J Med Entomol. 2021;58(3):1384-1388. https://doi.org/10.1093/jme/tjaa252

Vaughan JA, Hinson J, Andrews ES, Turell MJ. Pre-existing microfilarial infections of American Robins (Passeriformes: Turdidae) and Common Grackles (Passeriformes: Icteridae) have limited impact on enhancing dissemination of West Nile virus in Culex pipiens Mosquitoes (Diptera: Culicidae). J Med Entomol. 2021;58(3):1389-1397. https://doi.org/10.1093/jme/tjaa261

Vietri NJ, Tobery SA, Chabot DJ, et al. Clindamycin protects nonhuman primates against inhalational anthrax but does not enhance reduction of circulating toxin levels when combined with ciprofloxacin. J Infect Dis. 2021;223(2):319-325. https://doi.org/10.1093/infdis/jiaa365

Voss WN, Hou YJ, Johnson NV, et al. Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes. Science. 2021;372(6546):1108-1112. https://doi.org/10.1126/science.abg5268

Waag DM, Chance TB, Trevino SR, et al. Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei. Microb Pathog. 2021;155:104919. https://doi.org/10.1016/j.micpath.2021.104919

Wang Y, Howell KA, Brannan J, et al. Prominent neutralizing antibody response targeting the Ebolavirus glycoprotein subunit interface elicited by immunization. J Virol. 2021;95(8):e01907-20. https://doi.org/10.1128/jvi.01907-20

Warren TK, Kane CD, Wells J, et al. Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus. Sci Rep. 2021;11(1):19458. https://doi.org/10.1038/s41598-021-98971-0

White LE, Holland RL, Scruggs JL. What is your diagnosis? A scrotal lesion in a cynomolgus macaque. Vet Clin Pathol. 2021;50(2):302-304. https://doi.org/10.1111/vcp.12961

Wirchnianski AS, Wec AZ, Nyakatura EK, et al. Two distinct lysosomal targeting strategies afford Trojan horse antibodies with pan-filovirus activity. Front Immunol. 2021;12:729851. https://doi.org/10.3389/fimmu.2021.729851

Wuertz KMG, Barkei EK, Chen WH, et al. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge. NPJ Vaccines. 2021;6(1):129. https://doi.org/10.1038/s41541-021-00392-7

Yee JL, Prongay K, Van Rompay KKA, et al. Tuberculosis detection in nonhuman primates is enhanced by use of testing algorithms that include an interferon-γ release assay. Am J Vet Res. 2021;83(1):15-22. https://doi.org/10.2460/ajvr.21.08.0124